Coronavirus in Espirito Santo | A Case Report on the Evolution of COVID-19 in an Onboard Population / Coronavírus no Espírito Santo | Um relatório de caso sobre a evolução da COVID-19 numa população a bordo
DOI:
https://doi.org/10.34119/bjhrv4n4-157Keywords:
Coronavirus Infections, Public Health Surveillance, Sanitary Control of Harbors and Vessels.Abstract
Crew member arrived in Brazil on August 20, 2020, rapid test for COVID-19 with a negative result. On the 28th, already on board, he developed: fever, cough and malaise. On the 29th, was closely monitored for 2 hours and 30 minutes. In the first hour, he presented hypothermia, high blood pressure and tachycardia, requiring oxygen therapy, he presented in the last 90 minutes to hypothermia, an abrupt drop in blood pressure and bradycardia, ultimately evolving to hypothermia, lack of blood pressure and electrical activity of the heart. A review of the protocol for coping with COVID-19 is required.
References
Garcia LP, Duarte E. Intervenções não farmacológicas para o enfrentamento à epidemia da COVID-19 no Brasil. Epidemiol Serv Saude. 2020 apr 03;29(2):e2020222.
Fiho JMJ, Assunção AA, Algranti E, Garcia EG, Saito CA, Maeno M. A saúde do trabalhador e o enfrentamento da COVID-19. Rev. bras. saúde ocup. 2020 apr 17;45:e14.
Yamagishi T, Kamiya H, Kakimoto K, Suzuki M, Wakita T. Descriptive study of COVID-19 outbreak among passengers and crew on Diamond Princess cruise ship, Yokohama Port, Japan, 20 January to 9 February 2020. Euro Surveill. 11 de junho de 2020; 25(23): 2000272. Retraction of: Euro Surveill. 2020 jun 18; 25(24): 2006181.
Centers for Disease Control and Prevention – CDC [Internet]. Morbidity and Mortality Weekly Report (MMWR). Public Health Responses to COVID-19 Outbreaks on Cruise Ships — Worldwide, February–March 2020. 2020 mar 27; 69(12);347-352. [citado em 02 de novembro de 2020]. Disponível em: <https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e3.htm>.
Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics. Biol Proced Online. 2020 Aug 4;22:19
Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM et al. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Curr Cardiol Rep. 2020 Apr 21;22(5):32. Retraction of: Curr Cardiol Rep. 2020 May 13;22(5):36.
Minussi BB, Paludo EA, Passos JPB, Santos MJ, Mocellin O, Maeyama MA. Grupos de risco do COVID-19: a possível relação entre o acometimento de adultos jovens “saudáveis” e a imunidade. Brazilian Journal of Health Review, Curitiba, v. 3, n. 2, p.3739-3762, 2020.
Patel R, Babady E, Theel ES, Storch GA, Pinsky BA, St. George K, et al. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19. MBio; 11(2):e00722-20.
